BRPI0415480A - composição nutricional contra efeitos colaterais de quimioterapia ou radioterapia - Google Patents

composição nutricional contra efeitos colaterais de quimioterapia ou radioterapia

Info

Publication number
BRPI0415480A
BRPI0415480A BRPI0415480-0A BRPI0415480A BRPI0415480A BR PI0415480 A BRPI0415480 A BR PI0415480A BR PI0415480 A BRPI0415480 A BR PI0415480A BR PI0415480 A BRPI0415480 A BR PI0415480A
Authority
BR
Brazil
Prior art keywords
nutritional composition
side effects
composition against
radiotherapy side
against chemotherapy
Prior art date
Application number
BRPI0415480-0A
Other languages
English (en)
Inventor
Eduardo Schiffrin
Denis Breuille
Stephanie Blum-Sperisen
Anne Donnet-Hughes
Magali Faure
Claudia Roessle
Marco Enrico Turini
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of BRPI0415480A publication Critical patent/BRPI0415480A/pt
Publication of BRPI0415480B1 publication Critical patent/BRPI0415480B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pediatric Medicine (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Addiction (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"COMPOSIçãO NUTRICIONAL CONTRA EFEITOS COLATERAIS DE QUIMIOTERAPIA OU RADIOTERAPIA". A presente invenção refere-se a uma composição nutricional adequada para pacientes que sofrem quimioterapia e/ou radiação tais como pacientes com câncer. A composição, que pode estar em forma de pó ou líquida, compreende proteínas de trigo e caseína, TGF-<225> e glutamina livre.
BRPI0415480-0A 2003-10-16 2004-10-14 Composição nutricional contra efeitos colaterais de quimioterapia ou radioterapia BRPI0415480B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03023383.7 2003-10-16
EP03023383 2003-10-16
PCT/EP2004/011539 WO2005039318A1 (en) 2003-10-16 2004-10-14 Nutritional composition against side effects of chemotherapy of radiotherapy

Publications (2)

Publication Number Publication Date
BRPI0415480A true BRPI0415480A (pt) 2006-12-26
BRPI0415480B1 BRPI0415480B1 (pt) 2019-09-17

Family

ID=34354470

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0415480-0A BRPI0415480B1 (pt) 2003-10-16 2004-10-14 Composição nutricional contra efeitos colaterais de quimioterapia ou radioterapia

Country Status (14)

Country Link
US (1) US7468193B2 (pt)
EP (1) EP1675480B1 (pt)
JP (2) JP5473190B2 (pt)
CN (1) CN1889856B (pt)
AR (1) AR046184A1 (pt)
BR (1) BRPI0415480B1 (pt)
CA (1) CA2542652C (pt)
CO (1) CO5690615A2 (pt)
ES (1) ES2677868T3 (pt)
IL (1) IL175081A0 (pt)
MY (1) MY148289A (pt)
TW (1) TW200526134A (pt)
WO (1) WO2005039318A1 (pt)
ZA (1) ZA200603886B (pt)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1638418T3 (da) 2003-06-23 2012-09-17 Nestec Sa Aminosyretilsætning til et sundt mikrobiota-økosystem
US7572474B2 (en) 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US8075934B2 (en) 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
EP1776877A1 (en) 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
GB0612671D0 (en) * 2006-06-27 2006-08-09 Shs Int Ltd Nutritional formulation
CN101522056A (zh) * 2006-10-19 2009-09-02 雀巢产品技术援助有限公司 老年人的长期喂养
EP2081450A1 (en) * 2006-10-19 2009-07-29 Nestec S.A. Long-term feed - cancer patient
NZ555163A (en) * 2007-05-14 2010-05-28 Fonterra Co Operative Group Methods of immune or hematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer, cancer symptoms, or the symptoms of cancer treatments
RU2482705C2 (ru) * 2007-12-05 2013-05-27 Н.В. Нютрисиа Высокоэнергетическая жидкая энтеральная питательная композиция
MX2010008726A (es) * 2008-02-07 2010-08-31 Nestec Sa Composiciones y metodos para influir en la recuperacion a partir de actividad fisica intensa.
AU2009293476B2 (en) * 2008-09-19 2013-01-24 Institut Curie Nutritional support to prevent and/or mitigate bone marrow toxicity from a cancerous tumor
CA2736747C (en) * 2008-09-19 2018-02-27 Nestec S.A. Nutritional support to prevent or moderate bone marrow paralysis or neutropenia during anti-cancer treatment
US8986769B2 (en) * 2008-10-24 2015-03-24 Mead Johnson Nutrition Company Methods for preserving endogenous TGF-β
US8367354B2 (en) 2008-10-24 2013-02-05 Mead Johnson Nutrition Company Methods for determining the levels of TGF-β in a composition
US8350006B2 (en) 2008-10-24 2013-01-08 Mead Johnson Nutrition Company Methods for determining the bioactivity of TGF-β in a composition
US9724664B2 (en) 2009-03-27 2017-08-08 Bend Research, Inc. Spray-drying process
US8293264B2 (en) * 2009-05-11 2012-10-23 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
EP2251020A1 (en) * 2009-05-11 2010-11-17 Nestec S.A. Short-time high temperature treatment generates microbial preparations with anti-inflammatory profiles
JP2011201842A (ja) * 2010-03-26 2011-10-13 Kobayashi Pharmaceutical Co Ltd 腸由来細胞の増殖促進剤
PT2611530T (pt) 2010-09-03 2019-05-09 Bend Res Inc Aparelho de secagem por pulverização e métodos de utilização do mesmo
EP2611529B1 (en) 2010-09-03 2019-01-23 Bend Research, Inc. Spray-drying method
US9248584B2 (en) 2010-09-24 2016-02-02 Bend Research, Inc. High-temperature spray drying process and apparatus
WO2012089782A1 (en) * 2010-12-29 2012-07-05 Nestec S.A. Fiber and probiotics for reducing intestinal symptoms related to stress
CN103402532B (zh) * 2011-03-04 2015-01-28 丘比株式会社 肠内营养剂
WO2012141575A1 (en) 2011-04-14 2012-10-18 N.V.Nutricia Combination of epa, dpa and/or dha with a chemotherapeutic agent
US20120269929A1 (en) * 2011-04-22 2012-10-25 Hugh Lippman Fortified Milk-Based Nutritional Compositions
US8765201B2 (en) * 2011-06-08 2014-07-01 Creneau Creations, Inc. High calorie food product and method
PT3366143T (pt) 2011-06-20 2025-01-07 Heinz Co Brands H J Llc Composições e métodos probióticos
FR2979241B1 (fr) * 2011-08-30 2014-05-09 Nutrialys Medical Nutrition Sa Utilisation de compositions a faible teneur en polyamines dans la prevention ou le traitement des effets indesirables lies a un traitement anti-cancereux
US9693958B2 (en) 2013-03-15 2017-07-04 Cureport, Inc. Methods and devices for preparation of lipid nanoparticles
EP3470074B1 (en) 2013-05-10 2020-10-14 H.J. Heinz Company Brands LLC Probiotics
US20210169104A1 (en) * 2014-08-11 2021-06-10 Six Sigma Laboratories Llc Oral rehydration composition
WO2016067132A1 (en) 2014-10-31 2016-05-06 Bend Research Inc. Process for forming active domains dispersed in a matrix
MY187022A (en) 2015-05-14 2021-08-26 Professional Dietetics Spa Compositions comprising amino acids for use in the treatment of mucositides in neoplasia patients undergoing radiation therapy and/or chemotherapy
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
US10682325B2 (en) 2017-08-14 2020-06-16 Axcella Health Inc. Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wasting
JP2021527670A (ja) 2018-06-20 2021-10-14 アクセラ・ヘルス・インコーポレイテッドＡｘｃｅｌｌａ Ｈｅａｌｔｈ Ｉｎｃ． 筋肉中の脂肪浸潤の治療のための組成物及び方法
WO2020089384A1 (en) * 2018-11-01 2020-05-07 Société des Produits Nestlé S.A. Hard non-dairy cheese composition and process for preparation thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1285491C (en) * 1985-09-12 1991-07-02 Robert J. Smith Method of treating catabolic dysfunction
IL94549A (en) * 1989-06-02 1996-08-04 Brigham & Womens Hospital A pharmaceutical preparation containing glutamine
US5824297A (en) 1990-06-25 1998-10-20 Oncogene Science, Inc. Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
AUPN271295A0 (en) 1995-05-02 1995-05-25 Gropep Pty Ltd Method of treatment
DK0527283T3 (da) * 1991-08-12 1998-08-10 Nestle Sa Levnedsmiddelsammensætning
EP0818529B1 (fr) 1996-07-09 2005-06-22 Societe Des Produits Nestle S.A. Procédé de séchage par pulvérisation
ATE206873T1 (de) 1997-01-09 2001-11-15 Nestle Sa Probiotik enthaltendes getreideprodukt
CA2223198A1 (en) * 1997-01-14 1998-07-14 Societe Des Produits Nestle S.A. Composition and method for treatment of inflammatory conditions of the gastro-intestinal tract
EP0891719A1 (en) * 1997-07-14 1999-01-20 N.V. Nutricia Nutritional composition containing methionine
AUPP327198A0 (en) 1998-04-30 1998-05-21 Northfield Laboratories Pty Ltd A food composition and method of using same
GB9923048D0 (en) * 1999-09-29 1999-12-01 Nestle Sa Composition comprising casein protein and whey protein
JP2001128615A (ja) * 1999-11-04 2001-05-15 Ajinomoto Co Inc 乳幼児用調整粉乳
FR2802212B1 (fr) 1999-12-13 2002-03-01 Agronomique Inst Nat Rech Procede pour l'obtention d'une poudre contenant des micro-organismes viables, poudre obtenue selon ce procede et dispositif pour sa mise en oeuvre
AU7659601A (en) * 2000-08-07 2002-02-18 Discovery Life Pty Ltd Managing a life insurance investment
EP1343492B1 (en) * 2000-11-22 2006-02-01 Rxkinetix, Inc. Treatment of mucositis
CA2432884C (en) * 2000-12-27 2008-01-22 N.V. Nutricia Nutritional composition with health promoting action containing oligosaccharides
RU2302747C2 (ru) 2001-02-19 2007-07-20 Сосьете Де Продюи Нестле С.А. Продукт питания из злаков, содержащий пробиотический микроорганизм, продукт питания из злаков, содержащий метаболиты, продуцированные пробиотическими микроорганизмами, и способы их получения
CA2444470A1 (en) 2001-04-10 2002-10-24 Societe Des Produits Nestle S.A. Method and composition for prophylaxis of diabetes
EP1383527A4 (en) * 2001-04-24 2004-07-14 Gen Hospital Corp METHOD AND COMPOSITIONS FOR TREATING ORAL AND EYE EYE LESIONS
US6503506B1 (en) * 2001-08-10 2003-01-07 Millenium Biotechnologies, Inc. Nutrient therapy for immuno-compromised patients

Also Published As

Publication number Publication date
JP2012211139A (ja) 2012-11-01
US7468193B2 (en) 2008-12-23
WO2005039318A1 (en) 2005-05-06
CA2542652A1 (en) 2005-05-06
BRPI0415480B1 (pt) 2019-09-17
CN1889856A (zh) 2007-01-03
TW200526134A (en) 2005-08-16
ES2677868T3 (es) 2018-08-07
CA2542652C (en) 2014-05-13
ZA200603886B (en) 2007-11-28
JP2007508343A (ja) 2007-04-05
CO5690615A2 (es) 2006-10-31
JP5473190B2 (ja) 2014-04-16
EP1675480B1 (en) 2018-06-13
CN1889856B (zh) 2011-03-02
MY148289A (en) 2013-03-29
AR046184A1 (es) 2005-11-30
EP1675480A1 (en) 2006-07-05
IL175081A0 (en) 2006-08-20
US20070042021A1 (en) 2007-02-22

Similar Documents

Publication Publication Date Title
BRPI0415480A (pt) composição nutricional contra efeitos colaterais de quimioterapia ou radioterapia
BRPI0616987A2 (pt) pirazolopirimidinas como inibidores de cinase dependente de ciclina
IL186104A (en) Phosphoramidate History of Nucleoside Compounds
BRPI0923786C8 (pt) compostos 5,6-dihidro-6-fenilbenzo(f) isoquinolina-2- amina substituidos e composições farmacêuticas compreendendo ditos compostos
SG163583A1 (en) Anti-ctla-4 antibody and cpg-motif-containing synthetic oligodeoxynucleotide combination therapy for cancer treatment
BRPI0408247A (pt) usos de antagonistas e agonistas de il-23 e reagentes relacionados
CY1119766T1 (el) Νεοι ρυθμιστες κινασης βενζοπυρανιου
ECSP088350A (es) Pirazolopirimidinas como inhibidores de protein quinasas
MX2009013729A (es) Imidazopirazinas como inhibidores de proteina quinasa.
DK1951729T3 (da) Oxygenbundne pyrimidinderivater
MX2009003778A (es) Alimentacion a largo plazo para paciente de cancer.
MX2009005011A (es) Imidazopirazinas como inhibidores de proteina quinasa.
BRPI0507644A (pt) pirazolopirimidinas como inibidores de cinase dependente de ciclina
MY155710A (en) Composition for regulating lipid metabolism
MX2009012066A (es) Imidazopirinas sustituidas como inhibidoras de cinasa de lipido p13k.
BRPI0606891A2 (pt) anticorpos dr5 e usos dos mesmos
NO20090348L (no) Substituerte imidazolonderivater, sammensetninger og anvendelser av samme, samt fremgangsmater for fremstilling av samme
WO2007117657A3 (en) Transcobalamin receptor polypeptides, nucleic acids, and modulators thereof, and related methods of use in modulating cell growth and treating cancer and cobalamin deficiency
UA100540C2 (en) 2-benzylpyridazinone derivatives as met kinase inhibitors
MX2009004623A (es) Imidazopiridazinas como inhibidores de la lipido cinasa pi3k.
BR112013004436A2 (pt) composições e usos de materiais com atividade microbicida alta e toxicidade baixa
BRPI0610786B8 (pt) uso de um ou mais oligossacarídeos ácidos e neutros, e cisteína e/ou fonte de cisteína, e, composição alimentícia
UA99434C2 (ru) Применение производных алкилфосфолипидов со сниженной цитотоксичностью
MX2021015333A (es) Combinaciones de inhibidores para el tratamiento de enfermedades relacionadas con la expresion de dux4.
NO20082848L (no) Farmasoytisk formulering for behandling av osteoartritt inneholdende klodronsyre og hyaluronsyre

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM OS ARTIGOS 8O, 13 E 25 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A23L 33/19 (2016.01), A23L 33/00 (2016.01)

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 17/09/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 17/09/2019, OBSERVADAS AS CONDICOES LEGAIS

B25A Requested transfer of rights approved

Owner name: SOCIETE DES PRODUITS NESTLE S.A. (CH)

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 17A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2640 DE 10-08-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.